Yannis Trakadis, Bill Qi, Sameer Sardaar
2024 Cohort
Discover StageÌý

The traditional medical approach is "one size fits all", leading to resource inefficiency, extended delays, and prolonged treatment for patients. Bit Healix tackles this problem by leveraging genetic information and the power of AI to personalize diagnostic treatment, so patients can receive the right care the first time.

Karine Auclair and AndéanneÌýLupien
2024 Cohort
Discover StageÌý
AMR Winner

Antimicrobial resistance is on track to become one of the leading causes of death by 2050. Although a natural process, it is exacerbated by the abuse of antibiotics in people and animals. This method works to strengthen immune cells so they are better equipped to fight bacteria without antibiotics.

Changhong Cao
2024 Cohort
Develop StageÌý

Creating cutting-edge characterization devices for 2D materials-based electronics. Harnessing the unique properties of graphene, Cao’s micro-electromechanical system (MEMS) has potential to revolutionize the chip industry, offering an alternative to Silicon. - the industry standard since the 1950s.

Minh Tran and Thomas Szkopek
2024 Cohort
Develop StageÌý

With food demand exponentially growing, vertical farming offers a sustainable substitute to conventional farming that can help solve food scarcity and hunger. Monitoring nutrient levels is crucial for hydroponics, but current methods to do so are cost and labour intensive. Ikei has developed a user-friendly nutrient ion-sensor that farmers can use on-sight and in real time, drastically improving efficiency on farms and helping to scale the industry.

Devendra Pal, Parisa Ariya, and Robert Panetta
2024 Cohort
Develop StageÌý
AMR Winner

A first of its kind device for real-time detection of viruses and bacteria​, offering on-site diagnostics in milliseconds. Patholyzer is a smaller, portable Nano-digital inline holographic microscope used to identify and measure airborne pathogens. This project has enormous potential to fight against antimicrobial resistance (AMR), which poses one of the largest threats to human health in the coming century.

Sarah Kimmins and Bryan Martin
2024 Cohort
Deploy StageÌý

HisTurn is the first ever fertility treatment for men, featuring a genome-based technique to examine the epigenome of sperm. With a 94% accuracy in determining whether a sample is infertile, HisTurn is bound to change the Assisted Reproductive Technology industry.

Samson Bowen-Bronet
2023 Cohort
Develop StageÌý


Although wind and solar are widely seen as successful renewable energy alternatives to carbon-producing fossil fuels, their intermittent nature requires some kind of storage system to offset their fluctuating power generation. At grid-scale capacity, batteries are prohibitively expensive. Altiro Energy is developing a metal-powder based energy storage system that offers high capacity and reusability, at exceptionally low cost.

Mark Driscoll
2022 Cohort
Develop Stage (previously Launchpad Stage)

BioOptic™ seeks to offer a quick and easy way to measure one’s intra-abdominal pressure (IAP) which is shown to influence spinal stability and hence linked to back pain. Specifically, the device design and methods employed will be refined towards improving the accuracy, reliability, and usability of the device to get fully ready for market.

Hugo Level
2023 Cohort
Develop Stage

With a focus on biocompatible materials, this team is seeking to develop surface functionalization technology to improve vascular tissue repair. Normal stents used in heart surgery procedures fail 10% of the time in the five years following implantation. Capcyte’s solution aims to recruit the patient’s own cells to regenerate damaged tissue and enable human health.

Jianyu Li
2023 Cohort
Develop Stage


This project is focused on developing an alternative to the typical way we treat severe bleeding, i.e., using compressed gauze. This is an important issue as uncontrolled bleeding is leading cause of trauma-related deaths. The team has created a liquid-infused, micro-structured bio-adhesive that requires no compression to be effective, has a long shelf life and is as easy to use as conventional band-aids.

Professor Timothy Kennedy
2023 Cohort Deploy Stage
2022 Cohort Develop Stage


The team has developed a solution to prolong the life of human cells for research. A major challenge for long-term cell culture is that current cell culture substrate coatings are susceptible to degradation by proteases secreted by the cells. This destabilizes the culture, and typically results in cell death. DendroTEK’s game-changing technology provides long-term support for cell cultures, up to 5 times longer. An alumnus of the 1^st MIF cohort, the team has demonstrated its technology and is commercially active.

Sarah Kimmins
Develop Stage (2023 Cohort)
Discover Stage (2022 Cohort, previously Pre-Launch Stage)


Around the world, infertility rates are rising, but as couples seek medical interventions to resolve this issue, treatments often focus on female partners. However, the reality is in many cases, the cause is related to infertility of the male. HisTurn proposes a diagnostic to evaluate male sperm at the genetic level and identify associated behaviours that can help alleviate this problem.

Reza Sharif
2022 Cohort
Discover Stage (formerly Pre-Launch Stage)

Activation of peripheral pain sensing neurons (nociceptors) is central to the experience of pain, and several chronic pain conditions are caused by the sensitization of nociceptors to mechanical stimuli, including osteoarthritis and rheumatoid arthritis pain. We have identified an ion channel expressed in nociceptors and involved in sensing mechanical pain which represents a potential therapeutic target in chronic inflammatory pain. Determining a small molecule inhibitor to specifically target this ion channel would prevent the pain signal and may have valuable therapeutic potential in OA and RA patients, as well as other inflammatory pain conditions. to learn more.

Minh Tran
2023 Cohort
Discover Stage
Ìý

Traditional soil-grown crop production often means that the vegetables consumed in Canada have traveled huge distances before reaching our kitchens, which increase costs and the impact on the climate. But so-called vertical farming using hydroponic techniques require careful and regular monitoring of nutrient levels in order to ensure high yields. Ikei is developing a low-cost, user-friendly solution to this problem that will help increase profitability of water-based farms, which are known to be more efficient than soil-grown agriculture.

º«¹úÂãÎè, Harvard Medical School, and University of Montreal researchers
2022 Cohort
Deploy Stage (formerlyÌýBlastoff Stage)


INVICAREÌýdevelops an innovative biomedical technology to address infections around implants, with a two-fold approach to include prevention and more effective treatment. The company's core technology is a proprietary two-dimensional nanocrystalline hydrogel; the outcome of seven years of collaborative research between º«¹úÂãÎè scientists and researchers from Harvard Medical School and the University of Montreal.

Nathalie Tufenkji
2023 Cohort
Develop Stage

Conventional water filtration techniques rely on high amounts of chemicals used in large volume tanks that leaves behind a toxic sludge that can later pose serious environmental problems related to its disposal. The project proposes a low-cost, easy-to-manufacture solution that utilizes fibrous materials to act as a filtration mechanism. The solution would greatly simplify treating water, and would be more adaptable to both large and small-scale filtration systems.

Mahsa Jalali
2023 Cohort
Discover Stage

Cancer remains a leading cause of death in Canada. One of the keys to effective treatment is monitoring its progress, but this typically involves large pieces of equipment such as MRI machines, and often at infrequent intervals, e.g., every three months. The MoSERS team is developing a solution that can offer non-invasive, easy-to-use and accurate monitoring of cancer that only requires a tiny blood sample that is analyzed using a handheld device. Patients would have the ability to understand the disease’s progress more frequently, and the data would provide practitioners with better treatment options.

Changhong Cao
2022 Cohort
Discover Stage (formerlyÌýPre-launch Stage)

As silicon-based innovations have almost reached their physical limitations, the class of ultra-thin films is one of the most promising alternative building blocks for next-generation electronics to support a range of disruptive technologies including augmented reality (AR), autonomous vehicles (AV) and Internet of Things (IoT). However, evaluating the physical properties of 2DM-based devices has been a major obstacle because of their delicate nature. Our product enables the first discovery of the fracture toughness of functionalized graphene. More information is availableÌý.

Allen Ehrlicher
2022 Cohort
Develop Stage (formerly Launchpad Stage)


Cells are not only biochemical entities, but exert significant contractile forces. Defects in these forces are associated with a broad range of pathologies, from cancer and heart disease to asthma. PaCS offers a dramatically simpler, faster, and higher-content approach for contractility quantification. This represents the first industrial translation of cell forces methodologies to a practical and readily implementable approach.

2022 Cohort
Deploy Stage (formerly Blastoff Stage)


Every person at one point in their lifetime will experience change or deterioration in capacity to move owing to illness, accident, injury, or aging. Our premier product targets walking, the most valued activity contributing to quality of life. The Heel2Toe^TMÌýsensor (Class I Medical Device) helps improve the quality of a person’s gait, giving verbal instruction and feedback to place the heel first when walking. The sensor combined with supporting educational products in our Walk-BEST^TMÌýline (BEtter, Faster, Longer,ÌýSTronger) will make self-management of walking challenges a reality and support remote monitoring and rehabilitation of gait related impairments by therapists

Hamid Akbarzadeh
2023 Cohort
Discover Stage

Few would doubt the value of shock-absorbing materials such as those found in safety helmets or automobile bumpers. However, in practice they are disposable items that are thrown away after each major collision, thus creating significant environmental impact. The team is developing a bio-mimetic material that can reform after impact, enabling objects to withstand repeated impacts, which can lengthen the service life of the item, and reduce the volume of material that ends up in landfills.

Yee Wei Foong
2023 Cohort
Discover StageÌý

As the world moves to increased electrification of transport, demand for batteries will only increase. But the current standard battery material – lithium – poses several constraints, including long recharge times, expense and issues related to mining this element. The team is developing a nano-graphite battery that potentially offers up to 10x faster recharge times, longer life cycles and the same energy density, all without using rare materials like lithium.

Sara Mahshid
2022 Cohort
Develop Stage (formerly Launchpad Stage)

The project is targeted for molecular diagnosis of respiratory infections like COVID-19 and Influenza A/B via colorimetric detection of RNA in the saliva of the patients in a multiplex and automated fashion. The team's vision is to maintain the accuracy of the gold standard (PCR), while reducing the cost (15$ customer price), time (5 min turn around) and complexity (fully automated sample collection, preparation and detection). More can be seen in this video.